Hyperhomocysteinemia as a component of syndrome X

Metabolism: Clinical and Experimental

Volumn 52, Issue 11, 2003, Pages 1491-1495

  Oron Herman, Mor ^a,b   Rosenthal, Talma ^a,b   Sela, Ben Ami ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FRUCTOSE; HOMOCYSTEINE; INSULIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEEDING; HYPERHOMOCYSTEINEMIA; HYPERINSULINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR; SYNDROME X; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

EID: 0345375263     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(03)00262-2     Document Type: Article

References (47)

1. DeFronzo RA, Ferrannini E: Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
2. Ducimetiere P, Eschwege E, Papoz L, et al: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19:205-210, 1980
3. Pyorala M, Miettinen H, Laakso M, et al: Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Circulation 98:398-404, 1998
4. Dhawan J, Bray CL, Warburton R, et al: Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians: Genetic or environmental effect? Br Heart J 72:413-421, 1994
5. Sheu WH, Jeng CY, Young MS, et al: Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. Am J Med Sci 319:84-88, 2000
6. Despres JP, Lamarche B, Mauriege P, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
7. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
8. Gotto AM Jr: Triglycerides as a risk factor for coronary artery disease. Am J Cardiol 82:22Q-25Q, 1998
9. Stamler J, Stamler R, Liu K: High blood pressure role in coronary heart disease and implication for prevention and control, in Connor W, Bristow D (eds): Coronary Heart Diseases. Philadelphia, PA, Lippincott, 1985, pp 85-109
10. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATPIII). JAMA 285:2486-2497, 2001
11. Israelsson B, Brattstrom LE, Hultberg BL: Homocysteine and myocardial infarction. Atherosclerosis 71:227-233, 1988
12. Verhoef P, Kok FJ, Kruyssen DACM, et al: Plasma total homocysteine, B vitamins and risk of coronary atherosclerosis. Arterioscler Thromb Vasc Biol 17:989-995, 1997
13. Clarke R, Daly L, Robinson K, et al: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155, 1991
14. Graham I, Daly LE, Refsum HM, et al: Plasma homocysteine as a risk factor for vascular disease. European Concerted Action Project. JAMA 277:1775-1781, 1997
15. Boushey CJ, Beresford SAA, Omenn GS, et al: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049-1067, 1995
16. Wald NJ, Watt HC, Law MR, et al: Homocysteine and ischemic heart disease: Results from a prospective study with implications regarding prevention. Arch Intern Med 158:862-867, 1998
17. Perry IJ, Refsum H, Morris RW, et al: Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 346:1395-1398, 1995
18. Stampfer MJ, Malinow MR, Wilett WC, et al: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268:877-881, 1992
19. Arneson E, Refsum H, Bonaa KH, et al: Serum total homocysteine and coronary heart disease. Int J Epidemiol 24:704-709, 1995
20. Nygard O, Nordrehaug JE, Refsum H, et al: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
21. Ford ES, Smith SJ, Stroup DF, et al: Homocyst(e)ine and cardiovascular disease: A systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31:59-70, 2002
22. House JD, Jacobs RL, Stead LM, et al: Regulation of homocysteine metabolism. Adv Enzyme Regul 39:69-91, 1999
23. Gallistl S, Sudi K, Mangge H, et al: Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents. Diabetes Care 23:1348-1352, 2000
24. Giltay EJ, Hoogeveen EK, Elbers JM, et al: Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 139:197-198, 1998
25. Meigs JB, Jacques PF, Selhub J, et al: Fasting plasma homocysteine levels in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes Care 24:1403-1410, 2001
26. Pixa A, Pietzsch J, Julius U, et al: Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism. Amino Acids 18:289-298, 2000
27. Fonseca VA, Mudaliar S, Schmidt B, et al: Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism 47:686-689, 1998
28. Abbasi F, Facchini F, Humphreys MH, et al: Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal. Atherosclerosis 146:175-178, 1999
29. Godsland IF, Rosankiewiez JR, Proudler AJ, et al: Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 86:719-723, 2001
30. Emoto M, Kanda H, Shoji T, et al: Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes. Diabetes Care 24:533-538, 2001
31. Tobey TA, Mondon CE, Zavaroni I, et al: Mechanism of insulin resistance in fructose-fed rats. Metabolism 31:609-612, 1982
32. Jacobsen DW, Gatautis VJ, Green R, et al: Rapid HPLC determination of total homcysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 40:873-881, 1994
33. Lee KU: Oxidative stress markers in Korean subjects with insulin resistance syndrome. Diabetes Res Clin Pract 54:S29-33, 2001 (suppl 2)
34. De Pergola G, Pannacciulli N, Zamboni M, et al: Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese pre-menopausal woman. Diabetes Nutr Metab 14:253-258, 2001
35. Sanchez-Margalet V, Valle M, Ruz FJ, et al: Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem 13:75-79, 2002
36. Rosolova H, Simon J, Mayer O Jr, et al: Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res 51:93-98, 2002
37. Sheu WH, Lee WJ, Chen YT: Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Heart 13:14-20, 2000
38. Jacobs RL, House JD, Brosnan ME, et al: Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 47:1967-1970, 1998
39. Gursh MF, Baydas G, Cikim G, et al: Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats. Arch Med Res 33:305-307, 2002
40. Robillon JF, Canivet B, Candilo M, et al: Type 1 diabetes mellitus and homocyst(e)ine. Diabete Metab 20:494-496, 1994
41. Cronin C, McPartlin JM, Barry DG, et al: Plasma homocysteine concentrations in patients with type 1 diabetes. Diabetes Care 21:1843-1847, 1998
42. Dicker-Brown A, Fonseca VA, Fink LM, et al: The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-β-synthase: Studies in hepatocytes. Atherosclerosis 158:297-301, 2001
43. Fonseca V, Dicker-Brown A, Ranganathan S, et al: Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 49:736-741, 2000
44. Facchini E, Chen Y-DL, Hollenbeck CB, et al: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266:3008-3011, 1991
45. Zavaroni I, Mazza S, Fantuzzi M, et al: Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med 234:24-30, 1993
46. Potter Van Loon BJ, Kluft C, Radder JK, et al: The cardiovascular risk factor plasminogen activator inhibitor type I is related to insulin resistance. Metabolism 42:945-949, 1993
47. Reaven GM: Syndrome X: 6 years later. J Intern Med 236:13-22m 1994 (suppl 736)